Arterial Hypertension in Men in the Warmia and Masuria Region

NCT03559608 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2018-06-18

No results posted yet for this study

Summary

The primary aim of the study is to define the prevalence of arterial hypertension and risk factors of its development in an unselected group of Polish men from the region of Warmia and Mazury, considered as one of the most unprivileged in terms of social and employment status in Poland. Polish men life expectancy at birth is 74 years and is lower as polish women life expectancy at birth by 8 years. The difference in Western Europe is 5 years. ProM aims to investigate the prevalence of arterial hypertension as well as to increase the interest in its prevention and treatment in men from the region.

Conditions

  • Arterial Hypertension

Sponsors & Collaborators

  • Zaklady Farmaceutyczne Polpharma SA / Poland

    collaborator UNKNOWN
  • University of Warmia and Mazury

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2017-12-23
Completion
2022-12-23

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03559608 on ClinicalTrials.gov